Literature DB >> 24759129

Neurodevelopment, GABA system dysfunction, and schizophrenia.

Martin J Schmidt1, Karoly Mirnics2.   

Abstract

The origins of schizophrenia have eluded clinicians and researchers since Kraepelin and Bleuler began documenting their findings. However, large clinical research efforts in recent decades have identified numerous genetic and environmental risk factors for schizophrenia. The combined data strongly support the neurodevelopmental hypothesis of schizophrenia and underscore the importance of the common converging effects of diverse insults. In this review, we discuss the evidence that genetic and environmental risk factors that predispose to schizophrenia disrupt the development and normal functioning of the GABAergic system.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24759129      PMCID: PMC4262918          DOI: 10.1038/npp.2014.95

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  342 in total

Review 1.  Modes of neuronal migration in the developing cerebral cortex.

Authors:  Bagirathy Nadarajah; John G Parnavelas
Journal:  Nat Rev Neurosci       Date:  2002-06       Impact factor: 34.870

2.  Association within a family of a balanced autosomal translocation with major mental illness.

Authors:  D St Clair; D Blackwood; W Muir; A Carothers; M Walker; G Spowart; C Gosden; H J Evans
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321

3.  Mental health: On the spectrum.

Authors:  David Adam
Journal:  Nature       Date:  2013-04-25       Impact factor: 49.962

4.  Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients.

Authors:  S Akbarian; J J Kim; S G Potkin; W P Hetrick; W E Bunney; E G Jones
Journal:  Arch Gen Psychiatry       Date:  1996-05

5.  Volume, neuron density and total neuron number in five subcortical regions in schizophrenia.

Authors:  Pawel Kreczmanski; Helmut Heinsen; Valentina Mantua; Fritz Woltersdorf; Thorsten Masson; Norbert Ulfig; Rainald Schmidt-Kastner; Hubert Korr; Harry W M Steinbusch; Patrick R Hof; Christoph Schmitz
Journal:  Brain       Date:  2007-02-15       Impact factor: 13.501

Review 6.  Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology.

Authors:  Paul J Harrison; Amanda J Law
Journal:  Biol Psychiatry       Date:  2006-01-25       Impact factor: 13.382

7.  Rare chromosomal deletions and duplications increase risk of schizophrenia.

Authors: 
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

8.  Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice.

Authors:  Sandra Giovanoli; Harald Engler; Andrea Engler; Juliet Richetto; Mareike Voget; Roman Willi; Christine Winter; Marco A Riva; Preben B Mortensen; Joram Feldon; Manfred Schedlowski; Urs Meyer
Journal:  Science       Date:  2013-03-01       Impact factor: 47.728

Review 9.  Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.

Authors:  Lin Mei; Wen-Cheng Xiong
Journal:  Nat Rev Neurosci       Date:  2008-05-14       Impact factor: 34.870

10.  Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia.

Authors:  Ignacio Mata; Rocio Perez-Iglesias; Roberto Roiz-Santiañez; Diana Tordesillas-Gutierrez; Andres Gonzalez-Mandly; Ana Berja; Jose L Vazquez-Barquero; Benedicto Crespo-Facorro
Journal:  Neuroimage       Date:  2009-11-12       Impact factor: 6.556

View more
  64 in total

1.  Positive modulation of α5 GABAA receptors in preadolescence prevents reduced locomotor response to amphetamine in adult female but not male rats prenatally exposed to lipopolysaccharide.

Authors:  Bojan Batinić; Anja Santrač; Ivan Jančić; Guanguan Li; Aleksandra Vidojević; Bojan Marković; James M Cook; Miroslav M Savić
Journal:  Int J Dev Neurosci       Date:  2017-06-10       Impact factor: 2.457

2.  Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia.

Authors:  Felipe V Gomes; Jessica R Edelson; David W Volk; Anthony A Grace
Journal:  Schizophr Res       Date:  2018-04-26       Impact factor: 4.939

3.  Neurodevelopment and the origins of brain disorders.

Authors:  Pat Levitt; Jeremy Veenstra-VanderWeele
Journal:  Neuropsychopharmacology       Date:  2015-01       Impact factor: 7.853

Review 4.  Using human brain imaging studies as a guide toward animal models of schizophrenia.

Authors:  S S Bolkan; F Carvalho Poyraz; C Kellendonk
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

5.  The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis.

Authors:  Stephan F Taylor; Tyler B Grove; Vicki L Ellingrod; Ivy F Tso
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

Review 6.  A review of visual aftereffects in schizophrenia.

Authors:  Katharine N Thakkar; Steven M Silverstein; Jan W Brascamp
Journal:  Neurosci Biobehav Rev       Date:  2019-03-30       Impact factor: 8.989

Review 7.  Different Paths to Core Pathology: The Equifinal Model of the Schizophrenia Syndrome.

Authors:  Isobel W Green; Jill R Glausier
Journal:  Schizophr Bull       Date:  2015-09-20       Impact factor: 9.306

Review 8.  Brain rhythms connect impaired inhibition to altered cognition in schizophrenia.

Authors:  Benjamin R Pittman-Polletta; Bernat Kocsis; Sujith Vijayan; Miles A Whittington; Nancy J Kopell
Journal:  Biol Psychiatry       Date:  2015-02-14       Impact factor: 13.382

Review 9.  Dopamine: Functions, Signaling, and Association with Neurological Diseases.

Authors:  Marianne O Klein; Daniella S Battagello; Ariel R Cardoso; David N Hauser; Jackson C Bittencourt; Ricardo G Correa
Journal:  Cell Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.046

10.  Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model.

Authors:  Gen Kaneko; Basavaraju G Sanganahalli; Stephanie M Groman; Helen Wang; Daniel Coman; Jyotsna Rao; Peter Herman; Lihong Jiang; Katherine Rich; Robin A de Graaf; Jane R Taylor; Fahmeed Hyder
Journal:  Biol Psychiatry       Date:  2016-05-30       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.